Some of Thursday's midday movers:» Read More
Last year, I pointed out that the market historically has outperformed when an original NFL team wins the Super Bowl and lags when an original AFL team wins. This year is special then. Both the Cardinals and the Steelers were members of the original NFL before the merger with the AFL in 1970. So either way, an original NFL team will win this year. Of course the NY Giants upset of New England last year did not translate well for the markets...
Within about a 12-hour period, two healthcare companies have blamed the pullback in hospital spending for worse-than-anticipated financial results.
Futures dropped 5 points on disappointing guidance from Wal-Mart. We were expecting a poor December retail sales report, and for the most part it did not disappoint.
Some established firms have collapsed outright, others are laying off by the hundreds, and others still are seeking mergers with larger firms to try and weather the storm.
Another issue weighing on financials is the gradual realization that the government is dead serious about additional regulation, particularly of brokerage firms. Fed Chairman Ben Bernanke, speaking at an FDIC forum, argued that the Fed should have broader power to monitor the financial system.
Following are the day’s winners and losers. Find out why shares of Zimmer Holdings and Sepracor popped while EMC and Amazon dropped.
Stocks closed higher in another jittery session, helped by expectations of another Fed rate cut and an economic stimulus package from the federal government.
Cardinal Health reported an 11 percent rise in quarterly earnings on Monday, led by its clinical and medical products businesses, but cited disappointment with its main pharmaceutical supply chain segment.
Pharmaceutical wholesaler McKesson reported that its quarterly profit rose a better-than-expected 8 percent, led by increased demand for its drug distribution business, and the company raised its full-year earnings forecast.
What's the best way to stock a large-cap value fund?
Downey Financial, Freeport-McMoRan, WWE and more...Investing can be confusing. Luckily, Cramer has mapped out some road rules for all you Home Gamers trying to navigate the jungle that is Wall Street. Think of it as "Mad Money 101" –- some fundamental advice to keep in mind as you play the market. Whether you're a first time investor or a seasoned financier, it's always good to remember the basics.
Cardinal Health on Thursday said its quarterly net profit rose, led by strong demand for medical pumps and other devices in its Clinical Technologies and Services business.
As the push for universal health care in the U.S. heats up on Capitol Hill, market experts say generic drug stocks and pharmaceutical distributors should perform well, while the hit to big pharma may not be as bad as some anticipate.
Cardinal Health has agreed to pay $35 million to settle charges that it engaged in nearly a four-year fraudulent revenue and earnings scheme, the U.S. Securities and Exchange Commission said on Thursday.
M&A news and quarterly updates provided some of the catalysts behind the most actively traded stocks on Monday.
Stocks are looking for direction amid a flurry of takeover headlines this morning. Asian stocks were higher overnight on the back of Wall Street's Friday gains, but European markets are mostly weaker.
Cardinal Health said on Monday it would acquire Viasys Healthcare, which makes medical products for respiratory care and other uses, for about $1.5 billion, including debt.
New York Stock Exchange, Airgas, CMGI and many more...Investing can be confusing. Luckily, Cramer has mapped out some road rules for all you Home Gamers trying to navigate the jungle that is Wall Street. Think of it as "Mad Money 101" –- some fundamental advice to keep in mind as you play the market. Whether you're a first time investor or a seasoned financier, it's always good to remember the basics.
As far as Cramer is concerned, the Sirius-XM Satellite Radio proposed deal is just the first of many coming over the next two years as corporations race to beat a potential Democratic White House in 2008. But which companies are in the best poised to profit?
Cardinal, one of the nation's top three drug distributors, made good on newly appointed Chief Executive R. Kerry Clark's promise in November to sell the underperforming unit and focus on reshaping the company.